Product
소개
NuGel™ BindPro™ Protein Removal & Enrichment of Metabolites/Analytes From Serum or Plasma
Aqueous Protein Crash & Enrichment of Metabolites/Analytes From Serum or Plasma
• Serum and plasma protein removal, >95%
• Ammonium Acetate buffer system, simplifies analyte concentration
• Aqueous Protein Crash, linearly scalable, unlike chemical precipitation or
membrane filtration.
• Fast process, less than 30 minutes from application to separation
• Applicable for drug binding/screening, target analytes and metabolomics
• Species agnostic, tested species include: human, mouse, sheep,
bovine, goat, rat, calf
• Dry powder format, compatible with high throughput systems such as
96 well plate.
• NuGel™ BindPro™ supplied as a dry powder reagent; related product -
BindPro™ supplied as a suspension reagent
BindPro™ is an umbrella trademark for polymeric reagents designed as
alternatives to ultra-filtration and solvent precipitation for applications that
require protein removal and/or concentration in a more versatile or scalable format.
NuGel™ BindPro™ is engineered onto a bead format, based on passivated porous silica (NuGel™ platform) covalently bound to elastomeric poly-electrolytes. NuGel™ BindPro™ can be used in lieu of solvents for drug binding studies, for targeted analytes, or for metabolomic investigations.
사양
주문정보
관련자료
References
Lipoproteins Turner, Joseph D., R. Stuart Langley, Kelly L. Johnston, Katrin Gentil, Louise Ford, Bo Wu, Maia Graham et al. "Wolbachia lipoprotein stimulates innate and adaptive immunity through Toll-like receptors 2 and 6 to induce disease manifestations of filariasis." Journal of Biological Chemistry 284, no. 33 (2009): 22364-22378. Patent Bhogal, John, Shridhara Alva Karinka, Timothy P. Henning, David Cunningham, Udo Hoss, Andrew H. Naegeli, and John Latour. "Methods of Collecting and Analyzing Samples." U.S. Patent 20,120,296,189, issued November 22, 2012. |